Literature DB >> 16565484

Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.

Daniela Macconi1, Mauro Abbate, Marina Morigi, Stefania Angioletti, Marilena Mister, Simona Buelli, Maria Bonomelli, Peter Mundel, Karlhans Endlich, Andrea Remuzzi, Giuseppe Remuzzi.   

Abstract

Ameliorating the function of the glomerular barrier to circulating proteins by blocking angiotensin II (Ang II) translates into less risk of progression toward end-stage renal failure in diabetic and nondiabetic nephropathies. However, the mechanisms underlying this barrier protection are not clear. Specialized contacts between adjacent podocytes are major candidate targets, and the actin cytoskeleton is emerging as a regulatory element. Here, we present data demonstrating that Ang II induced reorganization of F-actin fibers and redistribution of zonula occludens-1 (ZO-1) that is physically associated with actin in murine podocytes. These effects were paralleled by increased albumin permeability across podocyte monolayers. The F-actin stabilizer jasplakinolide prevented both ZO-1 redistribution and albumin leakage, suggesting that actin cytoskeleton rearrangement is instrumental to podocyte permselective dysfunction induced by Ang II. Changes in both F-actin and ZO-1 patterns were confirmed in glomeruli of rat isolated perfused kidneys on short infusion of Ang II, leading to increased protein excretion. Podocyte dysfunction was mediated by Ang II type 1 receptor and was partly dependent on Src kinase-phospholipase C activation. These data demonstrate that strategies aimed at stabilizing podocyte-podocyte contacts and targeting the relevant intracellular signal transduction are crucial to renoprotection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565484      PMCID: PMC1606571          DOI: 10.2353/ajpath.2006.050701

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Angiotensin II controls p21ras activity via pp60c-src.

Authors:  B Schieffer; W G Paxton; Q Chai; M B Marrero; K E Bernstein
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

2.  Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.

Authors:  A Remuzzi; S Puntorieri; C Battaglia; T Bertani; G Remuzzi
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).

Authors:  P Ruggenenti; A Perna; L Mosconi; M Matalone; R Pisoni; F Gaspari; G Remuzzi
Journal:  Kidney Int Suppl       Date:  1997-12       Impact factor: 10.545

4.  Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.

Authors:  I Shirato; T Sakai; K Kimura; Y Tomino; W Kriz
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines.

Authors:  Daniel Schiwek; Nicole Endlich; Lawrence Holzman; Harry Holthöfer; Wilhelm Kriz; Karlhans Endlich
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

6.  Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man.

Authors:  D Drenckhahn; R P Franke
Journal:  Lab Invest       Date:  1988-11       Impact factor: 5.662

7.  Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats.

Authors:  Sigrid Hoffmann; Dirk Podlich; Brunhilde Hähnel; Wilhelm Kriz; Norbert Gretz
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

8.  Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.

Authors:  R Lapinski; N Perico; A Remuzzi; F Sangalli; A Benigni; G Remuzzi
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

9.  Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments.

Authors:  M Itoh; A Nagafuchi; S Moroi; S Tsukita
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

10.  The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium.

Authors:  E Schnabel; J M Anderson; M G Farquhar
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more
  33 in total

1.  Proteinuria: is it all in the foot?

Authors:  Pierre Ronco
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  When to initiate ACEI/ARB therapy in patients with type 1 and 2 diabetes.

Authors:  Kevin V Lemley
Journal:  Pediatr Nephrol       Date:  2010-03-30       Impact factor: 3.714

3.  Interventions for chronic kidney disease in people with sickle cell disease.

Authors:  Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2016-10

4.  ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.

Authors:  Akihiro Shimizu; Jianyong Zhong; Yoichi Miyazaki; Tatsuo Hosoya; Iekuni Ichikawa; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2012-03-15       Impact factor: 5.992

5.  Lipopolysaccharide induces inducible nitric oxide synthase-dependent podocyte dysfunction via a hypoxia-inducible factor 1α and cell division control protein 42 and Ras-related C3 botulinum toxin substrate 1 pathway.

Authors:  Ahmad K Mashmoushi; Jim C Oates
Journal:  Free Radic Biol Med       Date:  2015-03-09       Impact factor: 7.376

6.  The role of renin angiotensin system inhibition in kidney repair.

Authors:  Irene M van der Meer; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Fibrogenesis Tissue Repair       Date:  2010-05-04

7.  Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.

Authors:  Mauro Abbate; Carla Zoja; Daniela Corna; Daniela Rottoli; Cristina Zanchi; Nadia Azzollini; Susanna Tomasoni; Silvia Berlingeri; Marina Noris; Marina Morigi; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 10.121

8.  Intensified inhibition of renin-angiotensin system: a way to improve renal protection?

Authors:  Paolo Cravedi; Piero Ruggenenti; Giuseppe Remuzzi
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

9.  Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway.

Authors:  Elena Gagliardini; Norberto Perico; Paola Rizzo; Simona Buelli; Lorena Longaretti; Luca Perico; Susanna Tomasoni; Carla Zoja; Daniela Macconi; Marina Morigi; Giuseppe Remuzzi; Ariela Benigni
Journal:  Am J Pathol       Date:  2013-05-23       Impact factor: 4.307

10.  Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin.

Authors:  Anne-Cécile Huby; Maria-Pia Rastaldi; Kathleen Caron; Oliver Smithies; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.